Notes
MARKET UPDATES:
CONSUMER:
🔸 $DG upgraded to Overweight (BofA).
🔸 Macau casinos ($WYNN, $LVS, $MLCO, $MGM): Gaming revenue +0.8% YoY.
🔸 $LI: March deliveries 36,674 (+26.5% YoY).
🔸 $NIO: March deliveries 15,039 (+14% MoM).
🔸 $PVH: Q4 EPS $3.27 (beat), revenue -4.8% YoY.
🔸 $TSLA: Denmark sales -65.6% YoY.
🔸 $ULTA: Upgraded to Buy, price target raised to $423.
ENERGY & INDUSTRIALS:
🔸 $AAL, $DAL, $LUV: Downgraded (Jefferies).
🔸 Oil: Brent stabilizes after Trump’s Russia comments.
🔸 $CVX: Sells East Texas gas assets ($1.2B+ value).
🔸 $EE: 7M-share secondary offering priced at $26.50.
FINANCIALS:
🔸 $LPLA: 4.7M-share secondary offering at $320.
🔸 $V: $375M escrow deposit, reducing Class B shares.
🔸 $WRB: Downgraded (BofA).
HEALTHCARE:
🔸 $JNJ: $10B talc settlement rejected by U.S. judge.
🔸 Drugmakers: Lobby Trump to phase in pharma tariffs.
TECH & MEDIA:
🔸 $LYV, $SEAT: Fall after Trump’s executive order on ticket pricing.
🔸 $PRGS: Q1 EPS $1.31 (beat), raises full-year guidance.
🔸 $SPIR: Q4 EPS loss ($2.21), weak Q1 outlook.
#Downgrades - Mar 03, 2025
• $AGCO: Baird Downgrades to Neutral from Outperform - PT $100 (from $116)
• $CNH: Baird Downgrades to Neutral from Outperform - PT $15 (from $16)
• $DE: Baird Downgrades to Neutral from Outperform - PT $501
• $DG: Deutsche Bank Downgrades to Hold from Buy - PT $80 (from $90)
• $DV: Cannonball Research Downgrades to Neutral from Buy - PT $14
• $FOX: Arete Downgrades to Neutral from Buy - PT $66
• $FTAI: Stifel Downgrades to Hold from Buy - PT $123 (from $100)
• $KC: Nomura Downgrades to Neutral from Buy - PT $18.10 (from $6.70)
• $KRP: Raymond James Downgrades to Market Perform from Strong Buy
• $LUV: JPMorgan Downgrades to Underweight from Neutral - PT $25
• $SRE: Jefferies Downgrades to Hold from Buy - PT $77 (from $96)
• $TNDM: Bernstein Downgrades to Market Perform from Outperform - PT $25 (from $35)
• $TNDM: Wells Fargo Downgrades to Equal Weight from Overweight - PT $22 (from $38)
• $ZLAB: BofA Securities Downgrades to Neutral from Buy - PT $36.10 (from $29)
#Upgrades - Dec 06, 2024
• $ACN: Goldman Sachs Upgrades to Buy from Neutral - PT $420 (from $370)
• $ASAN: KeyBanc Upgrades to Sector Weight from Underweight
• $BRX: BMO Capital Upgrades to Outperform from Market Perform - PT $33
• $DG: BofA Securities Upgrades to Buy from Underperform - PT $95
• $EPAM: Goldman Sachs Upgrades to Buy from Neutral - PT $295 (from $235)
• $FTI: Jefferies Upgrades to Buy from Hold - PT $40 (from $29)
• $KC: UBS Upgrades to Buy from Neutral - PT $12.50 (from $4.20)
• $PCH: BMO Capital Upgrades to Outperform from Market Perform - PT $51
• $PJT: UBS Upgrades to Neutral from Sell - PT $175 (from $130)
• $PTON: UBS Upgrades to Neutral from Sell - PT $10 (from $2.50)
• $PUMP: JPMorgan Upgrades to Neutral from Underweight - PT $10
• $RIG: JPMorgan Upgrades to Neutral from Underweight - PT $5
• $RSG: BMO Capital Upgrades to Outperform from Market Perform - PT $238
• $SHOP: Loop Capital Upgrades to Buy from Hold - PT $140
• $SITE: Jefferies Upgrades to Buy from Hold - PT $175 (from $145)
• $TKR: Jefferies Upgrades to Buy from Hold
• $WSBC: Raymond James Upgrades to Strong Buy from Outperform - PT $44 (from $35)
• $WY: BMO Capital Upgrades to Outperform from Market Perform - PT $38
$DG RESULTS: Q3
• • EPS $0.89 vs. $1.26 y/y, EST $0.95
Net sales $10.18B, +5% y/y, EST $10.14B
• Gross margin 28.8% vs. 29% y/y, EST 28.4%
• SG&A as percentage of revenue 25.7% vs. 24.5% y/y, EST 24.8%
• Operating profit $323.8M, -25% y/y, EST $341.2M
NINE MONTH RESULTS
• Square footage growth +5.1%
• Net addition of stores 537
RESULTS: Q3
• ADJ EPS $0.24, EST $0.33
• Sales $1.35B, EST $1.37B
• ADJ operating income $16.2M, EST $19.9M
• Inventory $2.14B
STOCKS ON THE MOVE
$ONCO, up 82.4%
$CNEY, up 57.8%
$BMY: up 4.4% premarket, Gains as FDA approves its schizophrenia drug
China ADRs extend their rally on latest stimulus push
$BABA: up 0.4% premarket
$JD: up 2.6% premarket
$PDD, up 1.33% premarket
$LI: up 0.4% premarket
$SAVA: down 11.7% premarket, after SEC charges co for misleading Alzheimer's drug trial claims
$COST: down 1.0% premarket, after Q4 results; brokerages hike PT
$DG: down 2.5% premarket, Citi downgrades Dollar General citing tough sales recovery as Walmart takes market share
$ESTA: up 27.3% premarket, on US FDA nod for Motiva breast implants
$KMX: up 0.7% premarket, Brokerages raise Carmax PT on expectations of recovery in US used car market
$WVE: up 2.2% premarket, JP Morgan resumes coverage with 'overweight'
$IONQ: up 8.1% premarket, Gains on $54.5 mln contract with US Air Force Research Lab
$BMBL: down 2.2% premarket, Down after KeyBanc downgrades to 'sector weight'
#Downgrades - Sep 27, 2024
$AGIO: Leerink Partners Downgrades to Market Perform from Outperform - PT $56 (from $60)
$ASC: Fearnley Downgrades to Hold from Buy - PT $19
$BMBL: KeyBanc Downgrades to Sector Weight from Overweight
$CLDX: Wolfe Research Downgrades to Peerperform from Outperform
$DG: Citi Downgrades to Sell from Neutral - PT $73 (from $91)
$HPQ: BofA Securities Downgrades to Neutral from Buy - PT $37
$MEDP: UBS Downgrades to Neutral from Buy - PT $350 (from $420)
$SMAR: Citi Downgrades to Neutral from Buy - PT $56.50 (from $63)
$SMMT: Citi Downgrades to Neutral from Buy - PT $23 (from $19)
$STNG: Fearnley Downgrades to Hold from Buy - PT $80
$TRMD: Fearnley Downgrades to Hold from Buy
$VIPS: CCB Int'l Downgrades to Neutral from Outperform - PT $15.50